조제 약국 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 치료 분야별, 투여 경로별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global Compounding Pharmacy Market, valued at USD 12.98 Billion in 2024, is projected to experience a CAGR of 6.52% to reach USD 18.96 Billion by 2030. The global compounding pharmacy market encompasses the specialized practice of pharmacists creating tailored medications for individual patients, addressing unique therapeutic requirements that are not fulfilled by mass-produced pharmaceuticals. This customization may involve specific dosage forms, allergen removal, or enhanced palatability.

Key Market Drivers

The increasing demand for personalized medication is a primary catalyst for the Global Compounding Pharmacy Market. Patients frequently require pharmaceutical formulations precisely adjusted for specific allergies, unique dosage strengths, or alternative administration routes not commercially available. This customization is crucial for optimizing therapeutic outcomes and minimizing adverse reactions, driving demand for tailored solutions. According to the Alliance for Pharmacy Compounding, in their "2023-2024 Compounding Pharmacy Snapshot" published in July 2024, in the median hybrid pharmacy, 3% of all prescriptions were for compounded medications, demonstrating significant reliance on individualized preparations.

Key Market Challenges

The stringent and evolving regulatory environment presents a significant challenge to the global compounding pharmacy market. Varying jurisdictional oversight and complex compliance requirements for quality assurance and safety impose considerable operational complexities and financial burdens on compounding pharmacies. These escalating demands directly impede market expansion by increasing operating costs and diverting resources from potential growth initiatives. For instance, according to the Alliance for Pharmacy Compounding, in Fall 2023, 15% of all surveyed compounding pharmacies ceased hazardous drug compounding due to compliance costs associated with new USP Chapter <800> standards.

Key Market Trends

Advanced Compounding Technology Integration is a key driver for market growth, emphasizing the adoption of automation, robotics, and sophisticated software within compounding pharmacies. This integration aims to enhance precision, reduce the potential for human error, and improve overall operational efficiency, which is crucial for handling complex formulations and increasing production volumes while adhering to stringent quality standards. This trend supports pharmacies in meeting the evolving demands for customized medications. According to the Alliance for Pharmacy Compounding's demographic survey in Fall 2023, 529 unique 503A compounding pharmacies or 503B outsourcing facilities were represented, underscoring the significant number of entities potentially benefiting from these technological advancements.

Key Market Players

• Wedgewood Pharmacy
• B. Braun Medical Inc.
• Fagron NV
• Fresenius Kabi
• Clinigen Group PLC
• Dougherty's Pharmacy, Inc.
• Lorraine's Pharmacy
• Rx3 Compounding Pharmacy
• Institutional Pharmacy Solutions
• Mcguff compounding pharmacy services

Report Scope:

In this report, the Global Compounding Pharmacy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Compounding Pharmacy Market, By Therapeutic Area:

• Pain Management
• Hormone Replacement
• Dermal Disorders
• Nutritional Supplements
• Other Therapeutic Areas

Compounding Pharmacy Market, By Route of Administration:

• Oral
• Topical
• Parenteral
• Other Route of Administrations

Compounding Pharmacy Market, By End User:

• Humans
• Veterinary

Compounding Pharmacy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Compounding Pharmacy Market.

Available Customizations:

Global Compounding Pharmacy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Compounding Pharmacy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas)
  • 5.2.2. By Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations)
  • 5.2.3. By End User (Humans, Veterinary)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Compounding Pharmacy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Therapeutic Area
  • 6.2.2. By Route of Administration
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Compounding Pharmacy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Therapeutic Area
      • 6.3.1.2.2. By Route of Administration
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Compounding Pharmacy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Therapeutic Area
      • 6.3.2.2.2. By Route of Administration
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Compounding Pharmacy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Therapeutic Area
      • 6.3.3.2.2. By Route of Administration
      • 6.3.3.2.3. By End User

7. Europe Compounding Pharmacy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Therapeutic Area
  • 7.2.2. By Route of Administration
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Compounding Pharmacy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Therapeutic Area
      • 7.3.1.2.2. By Route of Administration
      • 7.3.1.2.3. By End User
  • 7.3.2. France Compounding Pharmacy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Therapeutic Area
      • 7.3.2.2.2. By Route of Administration
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Compounding Pharmacy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Therapeutic Area
      • 7.3.3.2.2. By Route of Administration
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Compounding Pharmacy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Therapeutic Area
      • 7.3.4.2.2. By Route of Administration
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Compounding Pharmacy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Therapeutic Area
      • 7.3.5.2.2. By Route of Administration
      • 7.3.5.2.3. By End User

8. Asia Pacific Compounding Pharmacy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Therapeutic Area
  • 8.2.2. By Route of Administration
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Compounding Pharmacy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Therapeutic Area
      • 8.3.1.2.2. By Route of Administration
      • 8.3.1.2.3. By End User
  • 8.3.2. India Compounding Pharmacy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Therapeutic Area
      • 8.3.2.2.2. By Route of Administration
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Compounding Pharmacy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Therapeutic Area
      • 8.3.3.2.2. By Route of Administration
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Compounding Pharmacy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Therapeutic Area
      • 8.3.4.2.2. By Route of Administration
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Compounding Pharmacy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Therapeutic Area
      • 8.3.5.2.2. By Route of Administration
      • 8.3.5.2.3. By End User

9. Middle East & Africa Compounding Pharmacy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Therapeutic Area
  • 9.2.2. By Route of Administration
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Compounding Pharmacy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Therapeutic Area
      • 9.3.1.2.2. By Route of Administration
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Compounding Pharmacy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Therapeutic Area
      • 9.3.2.2.2. By Route of Administration
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Compounding Pharmacy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Therapeutic Area
      • 9.3.3.2.2. By Route of Administration
      • 9.3.3.2.3. By End User

10. South America Compounding Pharmacy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Therapeutic Area
  • 10.2.2. By Route of Administration
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Compounding Pharmacy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Therapeutic Area
      • 10.3.1.2.2. By Route of Administration
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Compounding Pharmacy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Therapeutic Area
      • 10.3.2.2.2. By Route of Administration
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Compounding Pharmacy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Therapeutic Area
      • 10.3.3.2.2. By Route of Administration
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Compounding Pharmacy Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Wedgewood Pharmacy
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. B. Braun Medical Inc.
• 15.3. Fagron NV
• 15.4. Fresenius Kabi
• 15.5. Clinigen Group PLC
• 15.6. Dougherty's Pharmacy, Inc.
• 15.7. Lorraine's Pharmacy
• 15.8. Rx3 Compounding Pharmacy
• 15.9. Institutional Pharmacy Solutions
• 15.10. Mcguff compounding pharmacy services

16. Strategic Recommendations

17. About Us & Disclaimer